ReviewNeuronal signaling2021

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease.

Shamma Qarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.